{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:29:48Z","timestamp":1793158188510,"version":"4.5.0"},"reference-count":25,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2017,9,1]]},"DOI":"10.1001\/jamaoncol.2017.0424","type":"journal-article","created":{"date-parts":[[2017,4,18]],"date-time":"2017-04-18T11:12:25Z","timestamp":1492513945000},"page":"1190","source":"Crossref","is-referenced-by-count":542,"title":["Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer"],"prefix":"10.1001","volume":"3","author":[{"given":"Fergus J.","family":"Couch","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota"},{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermela","family":"Shimelis","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunling","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven N.","family":"Hart","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric C.","family":"Polley","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Na","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Hallberg","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Moore","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Thomas","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Lilyquist","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingjian","family":"Feng","sequence":"additional","affiliation":[{"name":"Huntsman Cancer Institute, Department of Dermatology, University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"McFarland","sequence":"additional","affiliation":[{"name":"Department of Clinical Diagnostics, Ambry Genetics Inc, Aliso Viejo, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Pesaran","sequence":"additional","affiliation":[{"name":"Department of Clinical Diagnostics, Ambry Genetics Inc, Aliso Viejo, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Huether","sequence":"additional","affiliation":[{"name":"Department of Clinical Diagnostics, Ambry Genetics Inc, Aliso Viejo, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"LaDuca","sequence":"additional","affiliation":[{"name":"Department of Clinical Diagnostics, Ambry Genetics Inc, Aliso Viejo, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth C.","family":"Chao","sequence":"additional","affiliation":[{"name":"Department of Clinical Diagnostics, Ambry Genetics Inc, Aliso Viejo, California"},{"name":"Now, Division of Genetics and Genomics, Department of Pediatrics, University of California\u2013Irvine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Goldgar","sequence":"additional","affiliation":[{"name":"Huntsman Cancer Institute, Department of Dermatology, University of Utah, Salt Lake City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill S.","family":"Dolinsky","sequence":"additional","affiliation":[{"name":"Department of Clinical Diagnostics, Ambry Genetics Inc, Aliso Viejo, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"11","key":"coi170012r1","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/gim.2014.40","article-title":"Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients.","volume":"16","author":"LaDuca","year":"2014","journal-title":"Genet Med"},{"issue":"4","key":"coi170012r2","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jmoldx.2012.03.002","article-title":"ColoSeq provides comprehensive lynch and polyposis syndrome mutational analysis using massively parallel sequencing.","volume":"14","author":"Pritchard","year":"2012","journal-title":"J Mol Diagn"},{"issue":"28","key":"coi170012r3","doi-asserted-by":"publisher","first-page":"12629","DOI":"10.1073\/pnas.1007983107","article-title":"Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing.","volume":"107","author":"Walsh","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"coi170012r4","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1200\/JCO.2014.57.1414","article-title":"Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer.","volume":"33","author":"Couch","year":"2015","journal-title":"J Clin Oncol"},{"issue":"23","key":"coi170012r5","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1056\/NEJMsr1501341","article-title":"Gene-panel sequencing and the prediction of breast-cancer risk.","volume":"372","author":"Easton","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"coi170012r6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/cncr.29010","article-title":"Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel.","volume":"121","author":"Tung","year":"2015","journal-title":"Cancer"},{"issue":"19","key":"coi170012r7","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1200\/JCO.2013.53.6607","article-title":"Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment.","volume":"32","author":"Kurian","year":"2014","journal-title":"J Clin Oncol"},{"issue":"8","key":"coi170012r8","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/gim.2014.176","article-title":"Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1\/2-negative patients with early-onset breast cancer.","volume":"17","author":"Maxwell","year":"2015","journal-title":"Genet Med"},{"key":"coi170012r9","doi-asserted-by":"publisher","first-page":"2469523","DOI":"10.1155\/2016\/2469523","article-title":"Beyond DNA: an integrated and functional approach for classifying germline variants in breast cancer genes.","volume":"2016","author":"Pesaran","year":"2016","journal-title":"Int J Breast Cancer"},{"issue":"5","key":"coi170012r11","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1056\/NEJMoa1603144","article-title":"Inherited DNA-repair gene mutations in men with metastatic prostate cancer.","volume":"375","author":"Pritchard","year":"2016","journal-title":"N Engl J Med"},{"issue":"4","key":"coi170012r12","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1001\/jamaoncol.2015.5495","article-title":"Inherited mutations in women with ovarian carcinoma.","volume":"2","author":"Norquist","year":"2016","journal-title":"JAMA Oncol"},{"issue":"6","key":"coi170012r13","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa1400382","article-title":"Breast-cancer risk in families with mutations in PALB2.","volume":"371","author":"Antoniou","year":"2014","journal-title":"N Engl J Med"},{"issue":"6","key":"coi170012r14","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1086\/421251","article-title":"CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies.","volume":"74","author":"CHEK2 Breast Cancer Case-Control Consortium","year":"2004","journal-title":"Am J Hum Genet"},{"issue":"4","key":"coi170012r15","doi-asserted-by":"publisher","first-page":"R73","DOI":"10.1186\/bcr2919","article-title":"Rare variants in the ATM gene and risk of breast cancer.","volume":"13","author":"Goldgar","year":"2011","journal-title":"Breast Cancer Res"},{"issue":"11","key":"coi170012r16","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/ng1902","article-title":"Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles.","volume":"38","author":"Seal","year":"2006","journal-title":"Nat Genet"},{"issue":"13","key":"coi170012r17","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1200\/JCO.2015.63.7454","article-title":"Panel testing for familial breast cancer: calibrating the tension between research and clinical care.","volume":"34","author":"Thompson","year":"2016","journal-title":"J Clin Oncol"},{"issue":"8","key":"coi170012r18","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/gim.2015.166","article-title":"Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing.","volume":"18","author":"Susswein","year":"2016","journal-title":"Genet Med"},{"issue":"2","key":"coi170012r19","doi-asserted-by":"publisher","first-page":"R27","DOI":"10.1186\/bcr3405","article-title":"Risk of breast cancer in Lynch syndrome: a systematic review.","volume":"15","author":"Win","year":"2013","journal-title":"Breast Cancer Res"},{"issue":"5","key":"coi170012r20","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1136\/jmedgenet-2015-103529","article-title":"No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing.","volume":"53","author":"Easton","year":"2016","journal-title":"J Med Genet"},{"issue":"5","key":"coi170012r21","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1007\/s13277-013-0830-z","article-title":"Significant association between Nijmegen breakage syndrome 1 657del5 polymorphism and breast cancer risk.","volume":"34","author":"Zhang","year":"2013","journal-title":"Tumour Biol"},{"issue":"12","key":"coi170012r22","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1002\/ajmg.a.35550","article-title":"Increased risk of breast cancer in women with NF1.","volume":"158A","author":"Madanikia","year":"2012","journal-title":"Am J Med Genet A"},{"issue":"9","key":"coi170012r23","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1038\/bjc.2015.78","article-title":"Age-specific risk of breast cancer in women with neurofibromatosis type 1.","volume":"112","author":"Seminog","year":"2015","journal-title":"Br J Cancer"},{"issue":"7616","key":"coi170012r24","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans.","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"key":"coi170012r25","article-title":"Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples.","author":"Walsh","journal-title":"Genet Med"},{"key":"coi170012r10","unstructured":"ExAC Browser (Beta). Exome Aggregation Consortium. http:\/\/exac.broadinstitute.org. Accessed August 31, 2015."}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamaoncology\/article-pdf\/3\/9\/1190\/17684746\/jamaoncology_couch_2017_oi_170012.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T17:46:29Z","timestamp":1561484789000},"score":1,"resource":{"primary":{"URL":"http:\/\/oncology.jamanetwork.com\/article.aspx?doi=10.1001\/jamaoncol.2017.0424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,1]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2017.0424","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9,1]]}}}